论文部分内容阅读
目的:分析经皮门静脉穿刺置管治疗肝癌的超声引导价值。方法:选取该院2013年5月至2015年8月收治的60例肝癌患者为研究对象,在征得患者同意下随机分为对照组及研究组各30例,对照组采取体位标志法穿刺置管治疗,研究组采取超声引导下经皮门静脉穿刺置管治疗,比较两组患者穿刺置管效果及临床疗效。结果:研究组经超声引导下经皮门静脉穿刺置管治疗,总有效率为90%,同期对照组为80%,组间差异具有统计学意义(P<0.05);一次穿刺成功率93.3%、一次置管成功率96.7%,与对照组83.3%、90%相比较,差异具有统计学意义(P<0.05)。结论:超声引导下经皮门静脉穿刺置管治疗肝癌效果更佳,一次性穿刺及置管成功率更高,值得在临床推广使用。
Objective: To analyze the value of percutaneous portal venous catheterization in the treatment of liver cancer. Methods: Sixty patients with HCC who were treated in our hospital from May 2013 to August 2015 were enrolled in this study. Patients were randomly divided into control group (n = 30) and study group (n = 30) In the treatment group, the study group was treated with percutaneous portal vein puncture and catheterization guided by ultrasound. The puncture and catheterization effects and clinical effects were compared between the two groups. Results: The total effective rate was 90% in the study group and 80% in the control group. The difference between the two groups was statistically significant (P <0.05). The success rate of primary puncture was 93.3% The success rate of primary catheterization was 96.7%, which was significantly different from 83.3% and 90% of the control group (P <0.05). Conclusion: Ultrasound-guided percutaneous portal vein catheterization is more effective in the treatment of liver cancer. One-time puncture and catheterization have a higher success rate, which is worthy of clinical promotion.